Page last updated: 2024-11-12

vialinin a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

vialinin A: free radical scavenger from an edible mushroom in China; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11563133
CHEMBL ID2012938
MeSH IDM0496101

Synonyms (15)

Synonym
858134-23-3
vialinin a
CHEMBL2012938
bdbm50437693
1,1'-(4,4'',5',6'-tetrahydroxy[1,1':4',1''-terphenyl]-2',3'-diyl) benzeneacetic acid ester
4,4'',5',6'-tetrahydroxy[1,1':4',1''-terphenyl]-2',3'-diyl ester benzeneacetic acid
NOJUKCRPSUMHQQ-UHFFFAOYSA-N
gtpl8669
[3,4-dihydroxy-2,5-bis(4-hydroxyphenyl)-6-(2-phenylacetyl)oxyphenyl] 2-phenylacetate
AKOS024458452
DTXSID00468621
Q27089142
terrestrin a
HY-103435
CS-0027883

Research Excerpts

Overview

Vialinin A is an extract from mushroom and is a specific USP4 inhibitor. It is an extremely potent inhibitor against tumor necrosis factor (TNF)-α production in rat basophilic leukemia (RBL-2H3) cells.

ExcerptReferenceRelevance
"Vialinin A (1) is an extremely potent inhibitor against tumor necrosis factor (TNF)-α production in rat basophilic leukemia (RBL-2H3) cells. "( Design and synthesis of a vialinin A analog with a potent inhibitory activity of TNF-α production and its transformation into a couple of bioprobes.
Abe, N; Koshino, H; Onose, J; Takahashi, S; Ye, YQ, 2012
)
2.12
"Vialinin A is an extract from mushroom and is a specific USP4 inhibitor."( Ubiquitously specific protease 4 inhibitor-Vialinin A attenuates inflammation and fibrosis in S100-induced hepatitis mice through Rheb/mTOR signalling.
Chen, D; Chen, M; Chen, Y; Chen, Z; Huang, X; Jin, L; Tu, Y; Wang, X; Xu, J; Xue, F, 2021
)
1.61
"Vialinin A is a potent inhibitor of TNF-α production and is released from RBL-2H3 cells."( Ubiquitin-specific peptidase 5, a target molecule of vialinin A, is a key molecule of TNF-α production in RBL-2H3 cells.
Abe, N; Koshino, H; Okada, K; Onose, J; Sugaya, K; Takahashi, S; Taniguchi, K; Yajima, A; Yajima, S; Ye, YQ; Yoshida, A; Yoshioka, Y, 2013
)
1.36
"Vialinin A is an extremely potent inhibitor of tumor necrosis factor (TNF)-α release from RBL-2H3 cells. "( Inhibitory effects of vialinin A and its analog on tumor necrosis factor-α release and production from RBL-2H3 cells.
Abe, N; Koshino, H; Okada, K; Onose, J; Sugaya, K; Takahashi, S; Taniguchi, K; Yajima, A; Yajima, S; Ye, YQ; Yoshioka, Y, 2012
)
2.14
"Vialinin A is a terphenyl derivative and was elucidated by spectroscopic and chemical methods."( Vialinin A, a novel potent inhibitor of TNF-alpha production from RBL-2H3 cells.
Abe, N; Koshino, H; Onose, J; Sugaya, K; Takahashi, S; Xie, C; Yasunaga, K; Ye, YQ; Yoshikawa, K, 2008
)
2.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Ubiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)IC50 (µMol)22.30003.00005.06676.8000AID761505
Ubiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)IC50 (µMol)5.90003.00004.45005.9000AID761509
Ubiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)Ki8.25004.00004.00004.0000AID761507; AID761509
Ubiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)IC50 (µMol)1.50001.50001.50001.5000AID761508
Sentrin-specific protease 1Homo sapiens (human)IC50 (µMol)1.76500.00642.64466.1000AID1637028; AID1637029
Sentrin-specific protease 1Homo sapiens (human)Ki1.00000.93001.00001.0700AID1637030; AID1637031
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (30)

Processvia Protein(s)Taxonomy
male germ cell proliferationUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
response to ischemiaUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
axon target recognitionUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
adult walking behaviorUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
regulation of macroautophagyUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
protein deubiquitinationUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
axonal transport of mitochondrionUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
eating behaviorUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
negative regulation of MAP kinase activityUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
positive regulation of glycolytic processUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
neuromuscular processUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
muscle cell developmentUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
cellular response to xenobiotic stimulusUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
proteolysisUbiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)
protein ubiquitinationUbiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic processUbiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)
protein K48-linked deubiquitinationUbiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)
negative regulation of ubiquitin-dependent protein catabolic processUbiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)
protein deubiquitinationUbiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)
spliceosomal tri-snRNP complex assemblyUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
proteolysisUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
protein deubiquitinationUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
negative regulation of protein ubiquitinationUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
regulation of protein stabilityUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
protein localization to cell surfaceUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
positive regulation of TORC1 signalingUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
positive regulation of transcription by RNA polymerase IISentrin-specific protease 1Homo sapiens (human)
proteolysisSentrin-specific protease 1Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processSentrin-specific protease 1Homo sapiens (human)
protein sumoylationSentrin-specific protease 1Homo sapiens (human)
protein desumoylationSentrin-specific protease 1Homo sapiens (human)
regulation of mRNA stabilitySentrin-specific protease 1Homo sapiens (human)
apoptotic signaling pathwaySentrin-specific protease 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (15)

Processvia Protein(s)Taxonomy
cysteine-type endopeptidase activityUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
cysteine-type deubiquitinase activityUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
protein bindingUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
omega peptidase activityUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
ubiquitin protein ligase bindingUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
alpha-2A adrenergic receptor bindingUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
ubiquitin bindingUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
cysteine-type endopeptidase activityUbiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)
cysteine-type deubiquitinase activityUbiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)
protein bindingUbiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)
zinc ion bindingUbiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)
ubiquitin bindingUbiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)
deubiquitinase activityUbiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)
cysteine-type deubiquitinase activityUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
protein bindingUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
adenosine receptor bindingUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
identical protein bindingUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
metal ion bindingUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
endopeptidase activitySentrin-specific protease 1Homo sapiens (human)
protein bindingSentrin-specific protease 1Homo sapiens (human)
deSUMOylase activitySentrin-specific protease 1Homo sapiens (human)
SUMO-specific endopeptidase activitySentrin-specific protease 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (12)

Processvia Protein(s)Taxonomy
plasma membraneUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
nucleoplasmUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
cytoplasmUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
endoplasmic reticulum membraneUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
cytosolUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
neuronal cell bodyUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
neuron projection terminusUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
axon cytoplasmUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
cytoplasmUbiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)
lysosomeUbiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)
cytosolUbiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)
nucleusUbiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)
cytosolUbiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)
nucleusUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
cytoplasmUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
lysosomeUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
cytosolUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
plasma membraneUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
nucleusUbiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)
nucleoplasmSentrin-specific protease 1Homo sapiens (human)
cytoplasmSentrin-specific protease 1Homo sapiens (human)
focal adhesionSentrin-specific protease 1Homo sapiens (human)
nuclear membraneSentrin-specific protease 1Homo sapiens (human)
nucleusSentrin-specific protease 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (29)

Assay IDTitleYearJournalArticle
AID761496Inhibition of cathepsin B (unknown origin) at 6.3 uM after 20 mins by fluorometric analysis2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Vialinin A is a ubiquitin-specific peptidase inhibitor.
AID761508Inhibition of human USP4 using Ub-AMC as substrate after 60 mins by fluorometric analysis2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Vialinin A is a ubiquitin-specific peptidase inhibitor.
AID654111Antiinflammatory activity in rat RBL2H3 cells assessed as inhibition of DNP-BSA-induced TNF-alpha production preincubated for 15 mins prior DNP-BSA challenge measured after 30 mins by ELISA2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Design and synthesis of a vialinin A analog with a potent inhibitory activity of TNF-α production and its transformation into a couple of bioprobes.
AID1126481Inhibition of DNP-BSA-stimulated TNF-alpha production in rat RBL2H3 cells preincubated for 15 mins followed by DNP-BSA addition measured after 3 hrs by ELISA2014Bioorganic & medicinal chemistry, Apr-15, Volume: 22, Issue:8
Structural elucidation and synthesis of vialinin C, a new inhibitor of TNF-α production.
AID761515Competitive binding affinity to human USP5 C335A mutant by SDS-PAGE analysis in presence of biotin-DMT2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Vialinin A is a ubiquitin-specific peptidase inhibitor.
AID1637032Inhibition of SENP1 in human KU812 cells preincubated for 20 mins followed by addition of HA-SUMO1-VS as substrate measured after 2 hrs by immunoblot analysis2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
Vialinin A and thelephantin G, potent inhibitors of tumor necrosis factor-α production, inhibit sentrin/SUMO-specific protease 1 enzymatic activity.
AID654112Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Design and synthesis of a vialinin A analog with a potent inhibitory activity of TNF-α production and its transformation into a couple of bioprobes.
AID1637027Inhibition of TNF-alpha production in mouse bone marrow-derived mast cells measured after 15 mins by ELISA2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
Vialinin A and thelephantin G, potent inhibitors of tumor necrosis factor-α production, inhibit sentrin/SUMO-specific protease 1 enzymatic activity.
AID761504Inhibition of human USP2 using Ub-AMC as substrate at 1 to 30 uM after 60 mins by fluorometric analysis2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Vialinin A is a ubiquitin-specific peptidase inhibitor.
AID1637030Binding affinity to recombinant human 6His-tagged SENP1 catalytic domain expressed in Escherichia coli2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
Vialinin A and thelephantin G, potent inhibitors of tumor necrosis factor-α production, inhibit sentrin/SUMO-specific protease 1 enzymatic activity.
AID761509Inhibition of wild type human USP5 expressed in Escherichia coli BL21(DE3) using Ub-AMC as substrate after 60 mins by fluorometric analysis2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Vialinin A is a ubiquitin-specific peptidase inhibitor.
AID761503Inhibition of human USP8 using Ub-AMC as substrate at 1 to 30 uM after 60 mins by fluorometric analysis2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Vialinin A is a ubiquitin-specific peptidase inhibitor.
AID1637031Binding affinity to full-length recombinant human 6His-tagged SENP1 expressed in Escherichia coli BL21 (DE3)2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
Vialinin A and thelephantin G, potent inhibitors of tumor necrosis factor-α production, inhibit sentrin/SUMO-specific protease 1 enzymatic activity.
AID761513Competitive binding affinity to human USP5 C335A/H818A mutant by SDS-PAGE analysis in presence of biotin-DMT2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Vialinin A is a ubiquitin-specific peptidase inhibitor.
AID761512Inhibition of wild type human USP5 expressed in Escherichia coli BL21(DE3) using K48-linked tetraubiquitin as substrate assessed as substrate hydrolysis at 10 uM after 15 mins by SDS-PAGE analysis2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Vialinin A is a ubiquitin-specific peptidase inhibitor.
AID761497Inhibition of calpain1/2 (unknown origin) using Suc-LLVY-AMC as substrate at 6.3 uM after 20 mins by fluorometric analysis2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Vialinin A is a ubiquitin-specific peptidase inhibitor.
AID761507Competitive inhibition of wild type human USP5 expressed in Escherichia coli BL21(DE3) using Ub-AMC as substrate2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Vialinin A is a ubiquitin-specific peptidase inhibitor.
AID761520Inhibition of TNF-alpha production in rat RBL2H3 cells after 16 hrs by ELISA2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Vialinin A is a ubiquitin-specific peptidase inhibitor.
AID1851299Inhibition of TNF-alpha production in rat RBL-2H3 cells2022Bioorganic & medicinal chemistry, 09-15, Volume: 70Anti-inflammatory and anticancer p-terphenyl derivatives from fungi of the genus Thelephora.
AID1637026Inhibition of TNF-alpha production in antigen-stimulated rat RBL2H3 cells measured after 15 mins by ELISA2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
Vialinin A and thelephantin G, potent inhibitors of tumor necrosis factor-α production, inhibit sentrin/SUMO-specific protease 1 enzymatic activity.
AID1637028Inhibition of recombinant human 6His-tagged SENP1 catalytic domain expressed in Escherichia coli preincubated for 15 mins followed by addition of SUMO1-AMC as substrate measured after 1 hr by fluorescence analysis2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
Vialinin A and thelephantin G, potent inhibitors of tumor necrosis factor-α production, inhibit sentrin/SUMO-specific protease 1 enzymatic activity.
AID1637029Inhibition of full-length recombinant human 6His-tagged SENP1 expressed in Escherichia coli BL21 (DE3) preincubated for 15 mins followed by addition of SUMO1-AMC as substrate measured after 1 hr by fluorescence analysis2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
Vialinin A and thelephantin G, potent inhibitors of tumor necrosis factor-α production, inhibit sentrin/SUMO-specific protease 1 enzymatic activity.
AID1851302Antiproliferative activity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs2022Bioorganic & medicinal chemistry, 09-15, Volume: 70Anti-inflammatory and anticancer p-terphenyl derivatives from fungi of the genus Thelephora.
AID761505Inhibition of human UCH-L1 using Ub-AMC as substrate after 60 mins by fluorometric analysis2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Vialinin A is a ubiquitin-specific peptidase inhibitor.
AID761506Inhibition of human UCH-L3 using Ub-AMC as substrate at 1 to 30 uM after 60 mins by fluorometric analysis2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Vialinin A is a ubiquitin-specific peptidase inhibitor.
AID1126480Inhibition of TNF-alpha production in rat RBL2H3 cells2014Bioorganic & medicinal chemistry, Apr-15, Volume: 22, Issue:8
Structural elucidation and synthesis of vialinin C, a new inhibitor of TNF-α production.
AID761516Competitive binding affinity to human recombinant USP5 after 1 hr by SDS-PAGE analysis in presence of biotin-DMT2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Vialinin A is a ubiquitin-specific peptidase inhibitor.
AID761514Competitive binding affinity to human USP5 H818A mutant by SDS-PAGE analysis in presence of biotin-DMT2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Vialinin A is a ubiquitin-specific peptidase inhibitor.
AID761519Binding affinity to USP5 in rat RBL2H3 cell extracts at 10 to 40 uM by SDS-PAGE analysis2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Vialinin A is a ubiquitin-specific peptidase inhibitor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (15.79)29.6817
2010's12 (63.16)24.3611
2020's4 (21.05)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.47 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.84 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]